Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Natera (NTRA)
NASDAQ:NTRA
Natera (NTRA) Stock Price & Analysis
686 Followers
NTRA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$36.90 - $117.23
Previous Close$105.98
Volume1.72M
Average Volume (3M)1.15M
Market Cap
$13.01B
Enterprise Value$13.21B
Total Cash (Recent Filing)$236.90M
Total Debt (Recent Filing)$430.37M
Price to Earnings (P/E)―
Beta1.47
Next Earnings
Aug 01, 2024EPS Estimate
-$0.69Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.13
Shares Outstanding122,802,694
10 Day Avg. Volume1,067,929
30 Day Avg. Volume1,147,022
Standard Deviation0.16
R-Squared0.25
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)17.19
Price to Sales (P/S)12.15
Price to Cash Flow (P/CF)-56.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue12.20
Enterprise Value/Gross Profit26.81
Enterprise Value/Ebitda-40.38
Forecast
1Y Price Target
$126.42Price Target Upside19.29% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
Natera News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceNTRA raised their FY24 revenue guidance to $1.42bn to $1.45bn, from previous expectations of $1.32bn to $1.35bn.
Product DevelopmentSignatera is emerging as a remarkable product for NTRA, that holds potential to drive even higher growth going forward with a sizable $20B market, only 2% penetration today, strong reimbursement, indications expansion, potential to direct therapy, and competition taking 3-5 years to reach benchmarks that NTRA has already hit.
Technological AdvancementsNatera is leveraging AI and machine learning for competitive differentiation.
Bears Say
Survival BenefitAnalysts are less confident in overall survival benefit, which KOLs are looking for, given DFS benefit expected to be small.
Therapy EffectivenessDoubts about LONSURF being an effective therapy are present among experts.
Trial DesignConcerns exist around the trial design of ALTAIR, including LONSURF being introduced as 2nd or 3rd line therapy.
---
Ownership Overview
14.52% Insiders
33.85% Mutual Funds
16.21% Other Institutional Investors
35.42% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NTRA FAQ
What was Natera’s price range in the past 12 months?
Natera lowest stock price was $36.90 and its highest was $117.23 in the past 12 months.
What is Natera’s market cap?
Currently, no data Available
When is Natera’s upcoming earnings report date?
Natera’s upcoming earnings report date is Aug 01, 2024 which is in 10 days.
How were Natera’s earnings last quarter?
Natera released its earnings results on May 09, 2024. The company reported -$0.56 earnings per share for the quarter, beating the consensus estimate of -$0.705 by $0.145.
Is Natera overvalued?
According to Wall Street analysts Natera’s price is currently Undervalued.
Does Natera pay dividends?
Natera does not currently pay dividends.
What is Natera’s EPS estimate?
Natera’s EPS estimate is -$0.69.
How many shares outstanding does Natera have?
Natera has 122,802,700 shares outstanding.
What happened to Natera’s price movement after its last earnings report?
Natera reported an EPS of -$0.56 in its last earnings report, beating expectations of -$0.705. Following the earnings report the stock price went up 10.194%.
Which hedge fund is a major shareholder of Natera?
Among the largest hedge funds holding Natera’s share is Farallon Capital Management, L.L.C.. It holds Natera’s shares valued at 359M.
---
Natera Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$126.42 (19.29% Upside)
$126.42 (19.29% Upside)
Blogger Sentiment
Bullish
NTRA Sentiment 80%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 2.8M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $775.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 0.3%
Last 30 Days ▲ 2.5%
Last 30 Days ▲ 2.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
119.28%
12-Months-Change
Fundamentals
Return on Equity
-50.59%
Trailing 12-Months
Asset Growth
11.32%
Trailing 12-Months
Company Description
Natera
Natera, Inc. engages in the discovery, development, and commercialization of genetic testing services. It offers Panorama Non-Invasive Prenatal Test, Horizon Carrier Screening, Spectrum Pre-implantation Genetic Screening and Spectrum Pre-implantation Genetic Diagnosis, Anora Products of Conception and Non-Invasive Paternity Testing. The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in San Carlos, CA.
---
NTRA Company Deck
---
NTRA Earnings Call
Q1 2024
0:00 / 0:00
---
NTRA Stock 12 Month Forecast
Average Price Target
$126.42
▲(19.29% Upside)
Technical Analysis
Best Analysts Covering NTRA
1 Year
1 Year Success Rate
15/18 ratings generated profit
1 Year Average Return
+45.97%
assigned a buy rating 2 months ago
Copying David Westenberg's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +45.97% per trade.
---